Tailored Juice-guided Eradication Therapy

• Status: Completed
• Trial end date: 2019-07-31
• Target enrollment: 0
• Participant gender: All

Summary

In this study, the investigators aim to investigate the efficacy of tailored anti-microbial susceptibility guided-therapy via gastric juice PCR, compared with empirical standard triple therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaohsiung Medical University
• Treatments: Amoxicillin; Clarithromycin; Levofloxacin; Ofloxacin; Rabeprazole

Criteria

Inclusion Criteria:

1. male or non-pregnant female aged more than 20 yeasrs

2. H.pylori infection

3. Mental and legal ability to give a written infomed consent

Exclusion Criteria:

1. pregnant women

2. previous allergic reaction to antibiotics (clarithromycin, amoxicillin, levofloxacin, metronidazole and Proton-pump inhibitor(rabeprazole)

3. patients with previous gastric surgery

4. the coexistence of serious concomitant illness(for example, decompensated liver cirrhosis, uremia)